These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations. Jacob JJ; Vasudevan K; Pragasam AK; Gunasekaran K; Veeraraghavan B; Mutreja A mBio; 2021 Aug; 12(4):e0118821. PubMed ID: 34281387 [TBL] [Abstract][Full Text] [Related]
4. [Monitoring the spread of the SARS-CoV-2 (Coronaviridae: Coronavirinae: Betacoronavirus; Sarbecovirus) variants in the Moscow region using targeted high-throughput sequencing]. Borisova NI; Kotov IA; Kolesnikov AA; Kaptelova VV; Speranskaya AS; Kondrasheva LY; Tivanova EV; Khafizov KF; Akimkin VG Vopr Virusol; 2021 Sep; 66(4):269-278. PubMed ID: 34545719 [TBL] [Abstract][Full Text] [Related]
5. Genomic surveillance of severe acute respiratory syndrome coronavirus 2 in Burundi, from May 2021 to January 2022. Nduwimana C; Nzoyikorera N; Ndihokubwayo A; Ihorimbere T; Nibogora C; Ndoreraho A; Hajayandi O; Bizimana JC; Diawara I; Niyonizigiye D; Nyandwi J BMC Genomics; 2023 Jun; 24(1):312. PubMed ID: 37301830 [TBL] [Abstract][Full Text] [Related]
6. Systematic Exploration of SARS-CoV-2 Adaptation to Vero E6, Vero E6/TMPRSS2, and Calu-3 Cells. Aiewsakun P; Phumiphanjarphak W; Ludowyke N; Purwono PB; Manopwisedjaroen S; Srisaowakarn C; Ekronarongchai S; Suksatu A; Yuvaniyama J; Thitithanyanont A Genome Biol Evol; 2023 Apr; 15(4):. PubMed ID: 36852863 [TBL] [Abstract][Full Text] [Related]
7. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants. Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 B.1.1.7 lineage rapidly spreads and replaces R.1 lineage in Japan: Serial and stationary observation in a community. Hirotsu Y; Omata M Infect Genet Evol; 2021 Nov; 95():105088. PubMed ID: 34560289 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 from COVID-19 Patients in the Republic of Moldova: Whole-Genome Sequencing Results. Morozov A; Nirca V; Victorova A; Poppert S; Frickmann H; Yamada C; Kacena MA; Rata S; Movila A Viruses; 2022 Oct; 14(10):. PubMed ID: 36298865 [TBL] [Abstract][Full Text] [Related]
10. Spatiotemporal genome diversity of SARS-CoV-2 in wastewater: a two-year global epidemiological study. Mandal M; Mandal S Environ Monit Assess; 2023 Dec; 196(1):44. PubMed ID: 38102322 [TBL] [Abstract][Full Text] [Related]
11. Assessment of basic reproduction number (R Islam A; Sayeed MA; Rahman MK; Zamil S; Abedin J; Saha O; Hassan MM Infect Genet Evol; 2021 Aug; 92():104884. PubMed ID: 33930563 [TBL] [Abstract][Full Text] [Related]
12. A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries. Ahmad SU; Hafeez Kiani B; Abrar M; Jan Z; Zafar I; Ali Y; Alanazi AM; Malik A; Rather MA; Ahmad A; Khan AA J Infect Public Health; 2022 Aug; 15(8):878-891. PubMed ID: 35839568 [TBL] [Abstract][Full Text] [Related]
13. Analysis of SARS-CoV-2 genomic surveillance data during the Delta and Omicron waves at a Saudi tertiary referral hospital. Obeid D; Al-Qahtani A; Almaghrabi R; Alghamdi S; Alsanea M; Alahideb B; Almutairi S; Alsuwairi F; Al-Abdulkareem M; Asiri M; Alshukairi A; Alkahtany J; Altamimi S; Mutabagani M; Althawadi S; Alanzi F; Alhamlan F J Infect Public Health; 2023 Feb; 16(2):171-181. PubMed ID: 36543031 [TBL] [Abstract][Full Text] [Related]
14. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants. Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299 [TBL] [Abstract][Full Text] [Related]
15. Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses. Kannan SR; Spratt AN; Cohen AR; Naqvi SH; Chand HS; Quinn TP; Lorson CL; Byrareddy SN; Singh K J Autoimmun; 2021 Nov; 124():102715. PubMed ID: 34399188 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the mutation dynamics of SARS-CoV-2 genome in the samples from Georgia State of the United States. Ahmad W; Ahmad S; Basha R Gene; 2022 Oct; 841():146774. PubMed ID: 35905853 [TBL] [Abstract][Full Text] [Related]
17. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread. Bui NN; Lin YT; Huang SH; Lin CW Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109 [TBL] [Abstract][Full Text] [Related]
18. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021. Bui NN; Lin YT; Huang SH; Lin CW Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355 [TBL] [Abstract][Full Text] [Related]
19. Mutations of SARS-CoV-2 Structural Proteins in the Alpha, Beta, Gamma, and Delta Variants: Bioinformatics Analysis. Khetran SR; Mustafa R JMIR Bioinform Biotechnol; 2023; 4():e43906. PubMed ID: 37485046 [TBL] [Abstract][Full Text] [Related]
20. Retrospective in silico mutation profiling of SARS-CoV-2 structural proteins circulating in Uganda by July 2021: Towards refinement of COVID-19 disease vaccines, diagnostics, and therapeutics. Odongo S; Okella H; Ndekezi C; Okee M; Namayanja M; Mujuni B; Sterckx YGJ; Kizito D; Radwanska M; Magez S; Ikwap K; Mwiine FN; Lutwama JJ; Ibingira C PLoS One; 2022; 17(12):e0279428. PubMed ID: 36548384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]